Bicycle Therapeutics raises $51.4 mln

Bicycle Therapeutics said June 1 it closed a 40 million pound ($51.4 million) Series B financing round led by Vertex Ventures HC. New investors Cambridge Innovation Capital and Longwood Fund also participated in the round, while existing investors Novartis Venture Fund, SROne, SVLS and Atlas Venture took part. Bicycle Therapeutics, of Cambridge, England, is a biotechnology company.

North AmericaUSBriefs